NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 237 filers reported holding NEKTAR THERAPEUTICS in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | 0.0% | 285 | +13.5% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 251 | +151.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 100 | +49.3% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 67 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 67 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 67 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 67 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 67 | +17.5% | 0.00% | – |
| Q4 2019 | $1,000 | -50.0% | 57 | -52.5% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 120 | +531.6% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 19 | -5.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 20 | +5.3% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 19 | -95.4% | 0.00% | -100.0% |
| Q1 2018 | $44,000 | +83.3% | 412 | +2.5% | 0.01% | +66.7% |
| Q4 2017 | $24,000 | – | 402 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |